To the full analysis
Buyback calculator for SBC Medical Group Holdings
SBC Medical Group Holdings stock: key metrics
SBCSBC Medical Group Holdings had an operating margin of 38.9% and a return on invested capital (ROIC) of 36% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2022 | 65.9% | 11.6% | 3.6% |
| 2023 | 70.9% | 36.5% | 20.3% |
| 2024 | 76.0% | 34.2% | 22.7% |
| 2025 | 73.3% | 38.9% | 29.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2022 | 6.0% | 14.3% | 2.8% |
| 2023 | 27.7% | 55.3% | 15.2% |
| 2024 | 23.9% | 61.3% | 17.5% |
| 2025 | 20.5% | 36.0% | 13.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 14 Aug 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.